Bachem Holding AG

CH

Health Care

8.785 ₽

Current price

Sell
8.785 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    66 / 240

  • Position in country

    209 / 449

  • Return on Assets, %

    7.2

    -2.7

  • Debt to Equity, %

    0

    15.1

  • Intangible assets and goodwill, %

    0.8

    4.7

  • Revenue CAGR 3Y, %

    12.8

    12.8

  • Revenue Y, % chg

    17.9

    0

  • P/E

    53.7

    32.1

  • P/BV

    4.5

    2

  • P/S

    10.4

    4.1

  • EV/S

    9.9

    3.6

  • EV/EBITDA

    32.9

    7.8

  • Average Analyst recommendation

    Sell

    Sell

  • Average upside forecasts, %

    836.5

    48.9

  • Forward P/E

    48

    25.5

  • Dividend Yield, %

    0.4

    0.8

  • Forward Dividend Yield, %

    10.3

    0.2

  • Expected dividend per share

    0.9

    0

  • Dividend Ex Date

    2024-04-26

Get an analytical review of this company

Competitors

Ranks

  • Siegfried Holding AG

    00%

  • SKAN Group AG

    00%

  • Lonza Group AG

    00%

  • Bachem Holding AG

    00%

  • Tecan Group AG

    00%

  • IQVIA Holdings Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • PolyPeptide Group AG

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Switzerland

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    6648.4

  • Ticker

    BCHMY.PK

  • ISIN

    US05636G1058

  • IPO date

    2001-06-29

  • Availability on Russian exchanges

    No

  • Reporting for

  • Date fact. publication of reports

Company Description

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: